Article
Single-cell profiling and zebrafish avatars reveal <i>LGALS1</i> as immunomodulating target in glioblastoma
2023-05-01
Abstract excerpt
Glioblastoma (GBM) remains the most malignant primary brain tumor, with a median survival rarely exceeding 2 years. Tumor heterogeneity and an immunosuppressive microenvironment are key factors contributing to the poor response rates of current therapeutic approaches. GBM-associated macrophages (GAMs) often exhibit immunosuppressive features that promote tumor progression. However, their dynamic interactions with...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2e0f8cf2-8bbc-507d-aed7-43df294b4e3b
- DOI
- 10.1101/2023.04.27.538517
